[TuAb0201] RAPID AND EFFICIENT ACUTE HIV DETECTION BY 4TH GENERATION AG/AB ELISA

16th International AIDS Conference

Toronto, Canada - August 13 - 18, 2006

RAPID AND EFFICIENT ACUTE HIV DETECTION BY 4TH GENERATION AG/AB ELISA

Int Conf AIDS. 2006 Aug 13-18;16 Abstract No. TuAb0201

R. De Souza¹, C. Pilcher², S. Fiscus², A. Cachafeiro², M. Kerkau², L. Scherer³, R.D. Sperhacke⁴, M. Silva⁴, S. Castro³, L.F. Brigido5, R. Ryder²
¹ Universidade de Caxias do Sul, Laboratorio de Pesquisa em HIV/AIDS, Caxias do Sul, Brazil, ² University of North Carolina at Chapel Hill, Center for AIDS Research, Chapel Hill, United States, ³ Laboratório Central do Município de Porto Alegre, Porto Alegre, Brazil, ⁴ Fundação Estadual de Pesquisa e Produção em Saúde, Porto Alegre, Brazil, 5 Instituto Adolfo Lutz, Divisão de Biologia Médica, Sao Paulo, Brazil

OBJECTIVES: HIV NAAT with specimen pooling can identify Ab-negative acute HIV infections (AHI), but is technologically complex and loses efficiency at high prevalences. Fourth-generation EIAs (FGEIA) detecting HIV Ab and p24 Ag simultaneously have not been directly compared to HIV NAAT for AHI detection.

METHODS: 933 consenting patients requesting HIV testing at a public HIV clinic in southern Brazil were screened with FGEIA (Genscreen Plus HIV Ag-Ab-Biorad) and NAAT (pooled 1:12). Confirmatory testing used parallel Axsym HIV1/2 gO MEIA (Abbott), IFA (Bio-manguinhos), Determine RT (Abbott) and WB (Genelabs). FGEA+ but Ab- or WB indeterminate specimens with available serum were confirmed by NAAT. HIV infection was defined by positivity on FGEIA and one or more confirmatory test; AHI was defined by one or more negative antibody test.

RESULTS: HIV was detected in 183 of 933 specimens (HIV prevalence: 19.6%). Five cases of Ab- negative infection (AHI prevalence: 0.5%) were all detected by FGEIA (Sensitivity (Se) 100.0 (95CI; 97.4,100.0)). FGEIA had no false positives (specificity (Sp) 100.0 (95CI; 99.3,100.0)). Pooled NAAT detected no additional cases.


#	FGEIA OD	MEIA	IF	Determine	WB	HIV NAAT	Subtype
1	Pos (3.136)	Pos	Neg	Pos	Pos	Pos	CB
2	Pos (2.897)	Neg	Neg	Pos	ND	QNS	QNS
3	Pos (0.442)	Neg	Neg	Pos	ND	Pos	QNS
4	Pos (0.950)	Pos	Pos	Pos	Indet	Pos	B
5	Pos (1.2)	Pos	Pos	Neg	Neg	QNS	QNS

CONCLUSIONS: In a clinic setting with high HIV prevalence and mixed subtypes in Southern Brazil, HIV antibody tests failed to detect 1 to 3% of confirmed HIV infections. Pooled NAAT offered no advantage over 4th generation EIA screening for detection of AHI. Simpler FGEIA screening detects AHI with sufficient accuracy to make acute HIV based prevention strategies feasible in resource limited settings.

Download PDF of this abstract.

Download Power Point Presentation.

2006-08-13
TuAb0201

Copyright © 2006 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.